Skip to main content

Handheld Device Allows Imaging and Treatment of Oral Cancer






Oral cancer is a growing public health concern, particularly in South Asia, where it affects tens of thousands each year. In India alone, oral cancer accounts for 40% of all cancers, largely driven by the widespread use of tobacco-based products. The situation is worsened by limited access to early screening and treatment, especially in rural and underserved areas. Most cases are diagnosed at advanced stages, when treatment is more difficult and survival rates are lower.

To address this problem, a team of researchers has developed a compact, affordable device that can both image suspicious lesions and deliver light-based therapy to treat them.

The device uses a smartphone-coupled intraoral probe with specialized LEDs and filters to capture white-light and fluorescence images to pinpoint oral cancers. It also includes laser diodes to activate a light-sensitive compound called protoporphyrin IX (PpIX), which accumulates in cancerous tissue after the application of a precursor drug, 5-aminolevulinic acid (ALA). When exposed to light, PpIX produces reactive molecules that destroy cancer cells while sparing healthy tissue. This approach, known as photodynamic therapy, has shown promise in treating early oral cancers with minimal side effects.

Simulated 3D oral tissues embedded with cancer cells were used to assess how deeply the device could detect and treat lesions. The system successfully imaged PpIX fluorescence up to 2.5 mm deep and showed effective photobleaching at depths relevant to early-stage oral cancers. To further test the technology, the device was used to deliver photodynamic therapy and monitor treatment in an animal model. There, tumors treated with the device shrank significantly compared to untreated controls. Histological analysis revealed tumor cell death extending up to 3.5 mm deep, consistent with light delivery simulations.

One of the device’s key features is its capability to monitor treatment in real time. By measuring the decrease in PpIX fluorescence during light exposure, the system provides feedback on how much therapeutic dose has been delivered. This could help ensure that each treatment is effective, even in settings without advanced medical infrastructure.

The researchers also used ratiometric imaging — comparing red and green fluorescence signals — to improve the accuracy of lesion detection and treatment monitoring. This method helps distinguish cancerous tissue from surrounding healthy areas, even in complex tissue environments.

The study demonstrates that a low-cost, portable device can perform both diagnosis and treatment of early oral cancer with promising accuracy and effectiveness. By combining imaging and therapy in a single tool, the technology could streamline care in regions where access to specialists is limited.

Future work will focus on clinical trials and refining the device for broader use. The team envisions a system that not only guides treatment but also adapts in real time, making photodynamic therapy more accessible and effective for patients around the world.


Bio Photonics Research Award

Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Laser Method Enables Fast & Precise Blood Vessels in Hydrogel

Researchers from Vienna University of Technology (TU Wien) and Keio University have found a way to create artificial blood vessels in miniature organ models in a quick and reproducible manner. The method utilizes ultrashort laser pulses in the femtosecond range to write highly 3D structures into a hydrogel. In biomedical research, organs-on-a-chip are becoming increasingly important: By cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. However, there has been a major obstacle: such mini-organs are incomplete without blood vessels. To facilitate systematic studies and ensure meaningful comparisons with living organisms, a network of perfusable blood vessels and capillaries must be created — in a way that is precisely controllable and reproducible. “We can create channels spaced only a hundred micrometers apart. That’s essential when you would like to...